Prognostic factors in renal cell carcinoma

被引:5
|
作者
Letang, N. [1 ]
Cabaniols, L. [1 ]
Pouessel, D. [2 ]
Robert, M. [1 ]
Iborra, F. [1 ]
Culine, S. [2 ]
Patard, J-J. [3 ]
Guiter, J. [1 ]
Thuret, R. [1 ]
机构
[1] Hop Lapeyronie, Serv Urol, F-34295 Montpellier 05, France
[2] CRLC Val Aurelle Paul Lamarque, Serv Oncol, F-34298 Montpellier 05, France
[3] Hop Pontchaillou, Serv Urol, F-35033 Rennes, France
关键词
renal carcinoma; kidney neoplasm; prognosis; survival; neoplam staging; INTEGRATED STAGING SYSTEM; CARBONIC-ANHYDRASE-IX; PREDICT SURVIVAL; MULTIINSTITUTIONAL VALIDATION; INTERNATIONAL MULTICENTER; INDEPENDENT PREDICTOR; RADICAL NEPHRECTOMY; PT2; CLASSIFICATION; COLLECTING SYSTEM; FAT INVASION;
D O I
10.1684/bdc.2009.0845
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Identification of prognostic factors in renal cell carcinoma is very important today for three goals: providing patient information, giving appropriate treatments and selecting patients for adapted treatment schedules as well as new clinical trials. Prognostic factors in RCC include: anatomical (TNM classification), histological (Fuhrmann grade and histological subtype), clinical (symptoms and performance status) and molecular factors. For improving predicative accuracy of prognostic systems such as the TNM classification, new prognostic algorithms or nomograms have been designed combining independent prognostic variables. UISS and SSIGN are the 2 most effective prognostic systems within localized RCC. In metastatic disease, the two main systems that have been used for predicting response to immunotherapy are the model of the French Group of Immunotherapy and the Motzer model. With the arrivals of new molecular factors, these systems will perhaps have to evaluate: these new systems will require further validation as part of large prospective clinical trials.
引用
收藏
页码:475 / 484
页数:10
相关论文
共 50 条
  • [31] Renal Cell Carcinoma and Prognostic Factors Predictive of Survival
    Sorbellini, M.
    Bratslavsky, G.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 362 - 363
  • [32] Prognostic factors and treatment decisions in renal cell carcinoma
    Ljungberg, B
    RENAL, BLADDER, PROSTATE AND TESTICULAR CANCER: AN UPDATE, 2001, : 37 - 46
  • [33] Prognostic factors of immunotherapy in metastatic renal cell carcinoma
    Padrik, P
    MEDICAL ONCOLOGY, 2003, 20 (04) : 325 - 334
  • [34] Prognostic Factors in Patients With Advanced Renal Cell Carcinoma
    Muriel, C.
    Esteban, E.
    Astudillo, A.
    Martinez-Camblor, P.
    Corral, N.
    Crespo, G.
    Berros, J. P.
    Fonseca, P. J.
    Luque, M.
    Lacave, A. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S523 - S523
  • [35] Prognostic factors and staging systems for renal cell carcinoma
    Ficarra, Vincenzo
    Galfano, Antonio
    Verhoest, Gregory
    Cavalleri, Stefano
    Martignoni, Guido
    Artibani, Walter
    Patard, Jean-Jacques
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (10) : 623 - 629
  • [36] Renal cell carcinoma: Prognostic factors and patient selection
    Belldegrun, Arie S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (07) : 477 - 483
  • [37] Prognostic factors of renal cell carcinoma: A multivariate analysis
    Yasunaga, Y
    Shin, M
    Miki, T
    Okuyama, A
    Aozasa, K
    JOURNAL OF SURGICAL ONCOLOGY, 1998, 68 (01) : 11 - 18
  • [38] Prognostic factors of immunotherapy in metastatic renal cell carcinoma
    Peeter Padrik
    Medical Oncology, 2003, 20 : 325 - 334
  • [39] Renal Cell Carcinoma and Prognostic Factors Predictive of Survival
    M. Sorbellini
    G. Bratslavsky
    Annals of Surgical Oncology, 2010, 17 : 362 - 363
  • [40] Prognostic factors and prognostic models for renal cell carcinoma: a literature review
    Tobias Klatte
    Sabrina H. Rossi
    Grant D. Stewart
    World Journal of Urology, 2018, 36 : 1943 - 1952